PubMed · 2010 · 46 citations · 27 references
MedicineOphthalmologyPharmacologyBiochemical PharmacologyMolecular PharmacologyOcular PharmacologyDiabetes MellitusDiabetes PharmacotherapyDiabetic RetinopathyRetinal PharmacotherapyBlood - Retinal BarrierBlood-retinal Barrier PermeabilityDiabetic Retinopathy Barrier BreakdownDiabetic Retinopathy ProgressionMatrix Metalloproteinase ModulationOcular Manifestations Of DiabetesRetinal Microvascular ChangesRetinal Thickness Analysis
Interruptions of Matrix Metalloproteinase-2 (MMP-2) and Matrix Metalloproteinase-9 (MMP-9) have been shown to reduce the ensuing threatening risk factors of vascular complications of diabetes by alteration in Extracellular Matrix (ECM). We hypothesized that minocycline induced MMP-2 and MMP-9 inhibition can be enhanced by aspirin, a non-selective COX and tPA inhibitor and this combination can reduce progression of diabetic retinopathy. Diabetes was induced in male Wistar rats by streptozotocin (55 mg/kg i.p.). Four weeks after diabetes induction rats were treated with minocycline (50 mg/kg, p.o.) per se, aspirin (50 mg/kg, p.o.) per se, or minocycline in combination with aspirin for a period of four weeks. At the end of eighth week rats were anesthetized and electroretinograms were recorded. B-wave latency, B-wave amplitude and retinal permeability were measured. Histology was done and retinal thickness was measured. Zymography was carried out for MMP-2 and MMP-9 level determinations. B-wave amplitude was significantly decreased while B- wave latency was significantly increased in diabetic group when compared with normo-glycemic rats. Treatment with combination of minocycline and aspirin significantly reversed B-wave amplitude and latency compared with vehicle-treated diabetic controls. Blood retinal permeability and retinal thickness were also significantly attenuated by the treatment of minocycline in combination with aspirin. Results of the present study suggest that MMP-2 and MMP-9 inhibition in presence of COX inhibitor prevents the development of experimental diabetic retinopathy in rats and can be a potential approach for the treatment.
27
David G. Cogan · Archives of Ophthalmology · 1961 · 810 citations
Medicine, Ophthalmology, Pathology +17
Matrix metalloproteinases: structures, evolution, and diversification
Irina Massova, Lakshmi P. Kotra, Rafael Fridman et al. · The FASEB Journal · 1998 · 775 citations
David A. Antonetti, Alistair J. Barber, Sarah K. Bronson et al. · Diabetes · 2006 · 738 citations
Diabetes Mellitus Enhances Vascular Matrix Metalloproteinase Activity
Shiro Uemura, Hidetsugu Matsushita, Wei Li et al. · Circulation Research · 2001 · 486 citations